Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Guardion Health Sciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q1 2021
- Shares held
- 2.73M
- +1.00M (+58.0%) vs. Q1 2021
- Total value
- $4.80M
- +$661.5K (+16.0%) vs. Q1 2021
- New holders
- 3
- 6 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,069,815 | $1.88M | 0.00% | +485,870+83.2% | Added |
| BlackRock Inc. | 571,933 | $1.01M | 0.00% | −55,331−8.8% | Reduced |
| Renaissance Technologies LLC | 347,291 | $611.0K | 0.00% | +69,810+25.2% | Added |
| Morgan Stanley | 326,987 | $575.0K | 0.00% | +313,509+2,326.1% | Added |
| Geode Capital Management, LLC | 169,865 | $298.0K | 0.00% | +27,400+19.2% | Added |
| State Street Corp | 131,112 | $231.0K | 0.00% | +131,112 | New |
| Virtu Financial LLC | 31,408 | $55.0K | 0.01% | +31,408 | New |
| Susquehanna Fundamental Investments, LLC | 27,600 | $49.0K | 0.00% | +27,600 | New |
| Citadel Advisors LLC | 25,204 | $44.0K | 0.00% | −27,495−52.2% | Reduced |
| Northern Trust Corp | 24,797 | $44.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,055 | $2.00K | 0.00% | +35+3.4% | Added |
| Signaturefd, LLC | 996 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 834 | $1.47K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 534 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9 | $0 | 0.00% | −825−98.9% | Reduced |
| Tower Research Capital LLC (TRC) | 73 | $0 | 0.00% | +23+46.0% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −779−100.0% | Sold out |